Serum Reverse Triiodothyronine and Thyroxine Kinetics in Patients with Chronic Renal Failure*
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Patients with chronic renal failure (CRF) have reduced serum total T3 (TT3) but normal total rT3 (TrT3) concentrations. These findings contrast with those of nonrenal nonthyroidal illnesses and malnutrition where low TT3 levels are associated with elevated TrT3 values. To evaluate the mechanisms for the normal TrT3 concentrations in CRF patients, iv bolus serum kinetic studies of labeled rT3 were carried out in 13 CRF and 8 normal subjects. In addition, T4 kinetics were studied in 7 CRF and 20 normal individuals. The CRF patients had normal or minimally reduced serum albumin [3.8 ± 0.2 (SE) g/dl] and transferrin (281 ± 17 mg/dl) levels and normal relative BW (95 ± 4%) and body mass index (23.0 ± 0.9 kg/m2) values, indicating adequate protein nutritional status. The mean serum TT3 levels were decreased to 62% of the normal mean (P < 0.001). There were significant increases in the mean values of the percent free fraction of rT3 (135% of normal mean, P < 0.001), free rT3 (131%, P < 0.001) and T4 binding globulin (TBG) (131%, P < 0.001) concentrations. The total and free serum T4 and percent free fraction values of T4 were normal, whereas the TT4/TBG ratio was reduced (75%, P < 0.025). Noncompartmental analysis of the rT3 kinetic data indicated that the apparent serum production and serum MCR of rT3 were normal in the CRF patients. The apparent total volume of distribution was increased to 242% of the normal mean (P < 0.001), the hormone pool to 232% (P < 0.005), the extravascular binding to 192% (P < 0.005), and the fractional rate of rT3 exit from serum (Kii) was increased to 235% (P < 0.005). The increase in Kii was greater than the increment in the free fraction of rT3 suggesting increased permeability of the hypothetical membrane enclosing the tissue space. The residence time was prolonged (258%, P < 0.001) despite reduced serum binding and the free or cellular rT3 clearance rate was reduced to 65% of the normal mean (P < 0.02) indicating decreased tissue degradation of rT3. The T4 kinetics showed normal serum production, MCR, residence time, total volume of distribution and pool size, and decreased Kii (48% of the normal mean, P < 0.005). The latter in association with a normal free fraction of T4 suggests the presence of impaired T4 transport out of serum. The alterations of rT3 and T4 metabolism in CRF can be accounted for by 1) decreased serum rT3 and T4 binding to TBG, 2) increased rT3 and reduced T4 transport out of serum due to factors in addition to reduced hormone binding to serum carrier proteins, 3) increased extravascular binding of rT3, and 4) impaired 5′-deiodination of T4 and rT3. The changes in T4 metabolism resemble those found in patients with nonrenal nonthyroidal illnesses. The increased fractional rate of rT3 exit from serum in CRF contrasts with the decrease found in nonrenal nonthyroidal disorders. A shift of rT3 from vascular to extravascular sites may account for the normal serum MCR and total serum rT3 concentrations observed in patients with CRF. These differences are probably related to the metabolic consequences or uremia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CHOPRA, I. J., CHOPRA, U., SMITH, S. R., REZA, M., & SOLOMON, D. H. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-6-1043 · Cited by 424
The role of glucocorticoids in the regulation of thyroid function in man
Nicoloff, J. T., Fisher, D. A., & Appleman, M. D. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106411 · Cited by 261
Self-citationThe effect of diphenylhydantoin on thyroxine metabolism in man
Larsen, P. R., Atkinson, A. J., Wellman, H. N., & Goldsmith, R. E. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106339 · Cited by 119
Cited by
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Peeters, R. P., Wouters, P. J., Kaptein, E., van Toor, H., Visser, T. J., & Van den Berghe, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022013 · Cited by 452
“The increase in serum rT3 levels is explained by a decrease in D1 activity because D1 is the principal pathway for rT3 clearance (15).”
BackgroundSelf-citationThyroid dysfunction and kidney disease
Iglesias, P., & Díez, J. J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0837 · Cited by 442
Hennemann, G., Docter, R., Friesema, E. C. H., de Jong, M., Krenning, E. P., & Visser, T. J. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.4.0435 · Cited by 394
“In patients with chronic renal failure, tissue transport of T4 was inhibited by 50%, but no data were presented for T3 production (181).”
BackgroundThe sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism
Docter, R., Krenning, E. P., de Jong, M., & Hennemann, G. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02401.x · Cited by 345
Metadata
- Authors
- KAPTEIN, E. M., FEINSTEIN, E. I., NICOLOFF, J. T., & MASSRY, S. G.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1983-07
- Volume
- 57
- Issue
- 1
- Pages
- 181-189
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2066358728
- Cited by
- 81
- References
- 3
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum Reverse Triiodothyronine and Thyroxine Kinetics in Patients with Chronic Renal Failure*. https://app.cochat.ai/papers/10.1210/jcem-57-1-181
- The paper
- KAPTEIN, E. M., FEINSTEIN, E. I., NICOLOFF, J. T., & MASSRY, S. G. (1983). Serum Reverse Triiodothyronine and Thyroxine Kinetics in Patients with Chronic Renal Failure*. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-57-1-181
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.